Masahiro Nakayama
Head And Neck Surgery
Tsukuba, Japan
Tsukuba, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Proton Beam Therapy for Sinonasal Neuroendocrine Carcinoma: A Six-Case Series with Dosimetric Comparison and Literature Review.
Journal: Journal of clinical medicine
Published: December 04, 2025
First-line pembrolizumab with or without chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up of the Japanese population of KEYNOTE‑048.
Journal: International journal of clinical oncology
Published: June 27, 2024
Frequency of use and cost in Japan of first-line palliative chemotherapies for recurrent or metastatic squamous cell carcinoma of the head and neck.
Journal: Japanese journal of clinical oncology
Published: May 02, 2024
Relationship between hearing loss and glasgow prognostic score in patients with cancer.
Journal: Auris, nasus, larynx
Published: April 16, 2024
THG-1/TSC22D4 Promotes IL-1 Signaling through Stabilization of TRAF6 in Squamous Cell Carcinoma.
Journal: Molecular cancer research : MCR
Published: February 08, 2024
Proton beam therapy in multimodal treatment for locally advanced squamous cell carcinoma of the nasal cavity and paranasal sinus.
Journal: Radiation oncology (London, England)
Published: May 16, 2023
Endoscopic observation of pharyngeal mucosal suture healing process after total laryngectomy: case series.
Journal: Acta oto-laryngologica
Published: April 27, 2023
Successful Treatment of Basaloid Squamous Cell Carcinoma of the Nasal Cavity With Brain Invasion.
Journal: Cureus
Published: February 21, 2023
In response to Inflammation-Based Score Predicts Pharyngocutaneous Fistula.
Journal: The Laryngoscope
Published: November 26, 2022
First-line pembrolizumab ± chemotherapy for recurrent/metastatic head and neck cancer: Japanese subgroup of KEYNOTE-048.
Journal: International journal of clinical oncology
Published: May 06, 2022
Last Updated: 09/26/2026